Our basic science and translational research team includes investigators, technicians, molecular epidemiologists and biostatisticians. Their laboratory efforts focus on cell interactions, development and regeneration. They also study how and why healthy cell processes go awry. Our Molecular Therapeutics Program develops front-line therapies for brain metastases as well as experimental therapies for recurrent tumors.
We are one of only a few centers nationwide with the ability to perform our own analysis of the vast amounts of data produced by genome sequencing.
Small teams of dedicated scientists work as teams in individual laboratories, each highly focused on one or more approaches to solving the problem of primary brain cancers or those that have metastasized to the brain from elsewhere in the body.
- SapC-DOPS nanovesicles for treatment of glioblastoma multiforme >>
- SapC-DOPS nanovesicles for enhanced brain imaging >>
- Energy utilization of primary and metastatic brain cancer cells >>
- KRas mutation >>
- Phosphoinositide signaling >>
- RO1 Grant: Targeting PI5P4Kβ in glioblastoma multiforme >>